Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Shield Therapeutics
Shield Therapeutics
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Accrufer
Ferric maltol
2019-07-25
2031-2035
Iron-deficiency anemia
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Ferric maltol
colonic neoplasms
,
heart failure
,
anemia
,
iron-deficiency anemia
,
iron deficiencies
Aspartame
opioid-related disorders
Nepidermin
rectal neoplasms
,
endometrial neoplasms
,
squamous cell carcinoma
,
squamous cell neoplasms
,
salivary gland neoplasms
,
endometrioid carcinoma
,
breast neoplasms
,
prostatic neoplasms
,
colorectal neoplasms
,
lung neoplasms
,
non-small-cell lung carcinoma
,
head and neck neoplasms
,
multiple myeloma
,
liver neoplasms
,
neoplasm metastasis
,
hypercholesterolemia
,
neoplasms
,
stomach neoplasms
,
pancreatic neoplasms
,
plasma cell neoplasms
,
osteoporosis
,
hepatocellular carcinoma
,
local neoplasm recurrence
,
huntington disease
,
multiple sclerosis
,
sclerosis
,
b-cell chronic lymphocytic leukemia
,
hyperlipoproteinemia type ii
,
myeloid leukemia acute
,
asthma
,
liver diseases
,
digestive system diseases
,
thyroid neoplasms
,
thyroid diseases
,
carcinoma
,
tonsillitis
,
recurrence
,
adenocarcinoma
,
drug therapy
,
heart failure
,
postmenopausal osteoporosis
,
pneumonia
,
gaucher disease
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use